- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT05214625
Questionnaire Study Concerning Artificial Intelligence
Questionnaire Study Concerning Artificial Intelligence and Its Application in (Gastrointestinal) Healthcare - Patients' and Physicians' Perspectives
Tutkimuksen yleiskatsaus
Yksityiskohtainen kuvaus
In recent years, important developments have been made in the field of artificial intelligence (AI). These developments have led to the large-scale application of AI in our everyday lives and AI-research within healthcare. A potentially promising application of AI lies in imaging analysis. For example, within gastroenterology this means the detection and classification of colorectal polyps and Barrett's neoplasia, disease severity scoring of inflammatory bowel diseases, and differentiating pancreatic cancer from chronic pancreatitis.
Despite the investments in AI-research, there is a lack in knowledge concerning patients' and physicians' perspectives on AI in healthcare. This prospective questionnaire study investigates these perspectives, obtaining data from both gastroenterology (GI) patients and GI-physicians within the Netherlands. The questionnaires focus on the knowledge, experience, and opinion of AI, particularly concerning the implementation of AI in (gastroenterology) healthcare. Furthermore, the current (endoscopic) infrastructure within Dutch hospitals will be investigated for its readnessy for AI.
Opintotyyppi
Ilmoittautuminen (Todellinen)
Yhteystiedot ja paikat
Opiskelupaikat
-
-
Limburg
-
Maastricht, Limburg, Alankomaat, 6202AZ
- Maastricht University Medical Center
-
-
Noord-Brabant
-
Eindhoven, Noord-Brabant, Alankomaat, 5623 EJ
- Catharina Ziekenhuis Eindhoven
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Näytteenottomenetelmä
Tutkimusväestö
Gastroenterology patients who will have an outpatient appointment for an endoscopic procedure in the context of the national bowel cancer screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases, in one of two Dutch hospitals between April 2020 and September 2020.
Gastroenterologists and gastroenterology fellows working in Dutch hospitals.
Kuvaus
Inclusion Criteria:
- Gastrointestinal (GI) patients with an outpatient appointment in the gastroenterology department for an endoscopic procedure in the context of the Dutch national screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases (in one of the two participating hospitals);
- Gastroenterologists working in Dutch hospitals;
- Gastroenterology fellows working in Dutch hospitals;
- Minimal age of 18 years old.
Exclusion Criteria:
- No appropriate understanding of the Dutch language;
- Not willing to sign informed consent;
- Objection to participate in medical scientific research, reported in the medical file.
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
Kohortit ja interventiot
Ryhmä/Kohortti |
Interventio / Hoito |
|---|---|
|
Gastroenterology patients
Patient receiving an endoscopic procedure because of regular care will be considered eligible for inclusion. Patients receive an endoscopic procedure in the context of the Dutch national screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases. Patients will be asked to complete a questionnaire concerning AI. No intervention will be administered. |
Questionnaire concerning artificial intelligence and its implementation in healthcare.
GI patients and GI physicians will be provided with slightly different questionnaires.
|
|
Gastroenterology physicians
GI physicians (both gastroenterologists and gastroenterology fellows), participating in a yearly gastroenterology and hepatology training day, will be asked for their participation in this study. Physician will be asked to complete a questionnaire concerning AI. No intervention will be administered. |
Questionnaire concerning artificial intelligence and its implementation in healthcare.
GI patients and GI physicians will be provided with slightly different questionnaires.
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
The knowledge on AI investigated by means of a questionnaire
Aikaikkuna: 6 months
|
The knowledge on AI in healthcare among gastroenterology patients and physicians, investigated by means of a questionnaire.
|
6 months
|
|
The experience with AI investigated by means of a questionnaire
Aikaikkuna: 6 months
|
The experience with AI (in healthcare) among gastroenterology patients and physicians, investigated by means of a questionnaire.
|
6 months
|
|
The opinion on AI investigated by means of a questionnaire
Aikaikkuna: 6 months
|
The oninion on AI in healthcare among gastroenterology patients and physicians, investigated by means of a questionnaire.
|
6 months
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Willingness of physicians to use AI in (gastroenterology) healthcare
Aikaikkuna: 6 months
|
The willingness to apply AI in (gastroenterology) healthcare among gastroenterology physicians.
|
6 months
|
|
Willingness to apply AI in (gastroenterology) healthcare
Aikaikkuna: 6 months
|
The willingness of gastroenterology patients for their physicians to apply AI in (gastroenterology) healthcare.
|
6 months
|
|
Advantages and disadvantages of AI use in (gastroenterology) healthcare
Aikaikkuna: 6 months
|
Important advantages and disadvantages of AI use in (gastroenterology) healthcare among gastroenterology patients and physicians.
|
6 months
|
|
Potential domains within gastroenterology and hepatology for AI use
Aikaikkuna: 6 months
|
Potential domains within gastroenterology and hepatology for AI use indicated by GI physicians.
|
6 months
|
|
Mandatory infrastructure for AI use in healthcare
Aikaikkuna: 6 months
|
The availability of technical facilities and infrastructures within endoscopy to implement and apply AI in Dutch hospitals.
|
6 months
|
Yhteistyökumppanit ja tutkijat
Sponsori
Yhteistyökumppanit
Tutkijat
- Päätutkija: Ad Masclee, Prof Dr MD, Maastricht Universitair Medisch Centrum
Julkaisuja ja hyödyllisiä linkkejä
Yleiset julkaisut
- Le Berre C, Sandborn WJ, Aridhi S, Devignes MD, Fournier L, Smail-Tabbone M, Danese S, Peyrin-Biroulet L. Application of Artificial Intelligence to Gastroenterology and Hepatology. Gastroenterology. 2020 Jan;158(1):76-94.e2. doi: 10.1053/j.gastro.2019.08.058. Epub 2019 Oct 5.
- Shaban-Nejad A, Michalowski M, Buckeridge DL. Health intelligence: how artificial intelligence transforms population and personalized health. NPJ Digit Med. 2018 Oct 2;1:53. doi: 10.1038/s41746-018-0058-9. eCollection 2018.
- Labovitz DL, Shafner L, Reyes Gil M, Virmani D, Hanina A. Using Artificial Intelligence to Reduce the Risk of Nonadherence in Patients on Anticoagulation Therapy. Stroke. 2017 May;48(5):1416-1419. doi: 10.1161/STROKEAHA.116.016281. Epub 2017 Apr 6.
- Waymel Q, Badr S, Demondion X, Cotten A, Jacques T. Impact of the rise of artificial intelligence in radiology: What do radiologists think? Diagn Interv Imaging. 2019 Jun;100(6):327-336. doi: 10.1016/j.diii.2019.03.015. Epub 2019 May 6.
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- METC 2020-2281
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
IPD-suunnitelman kuvaus
IPD-jaon aikakehys
IPD-jaon käyttöoikeuskriteerit
IPD-jakamista tukeva tietotyyppi
- STUDY_PROTOCOL
- MAHLA
- ICF
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .